CTIS.eu › Cities › Greece › Chaidari
Chaidari
Greece
117 total trials
80 recruiting
2023-503539-16-00
5
2025-11-11
Non-small Cell Lung Cancer (NSCLC)
2024-516745-39-00
4
2025-07-11
Cutaneous lupus erythematosus
2024-514064-17-00
3
2025-05-23
Pulmonary Arterial Hypertension
2024-516609-22-00
5
2025-04-15
Primary Sjögren’s Disease
2024-512998-27-00
5
2025-02-21
Non-Small Cell Lung Cancer
2024-513208-32-00
5
2024-12-16
Chronic Spontaneous Urticaria
2023-509069-19-00
4
2024-12-12
idiopathic pulmonary fibrosis
2024-515870-28-00
5
2024-10-22
Moderate to severe systemic lupus erythematosus
2023-505023-31-00
5
2023-11-17
Renal cell carcinoma
2024-515047-31-00
5
2023-08-28
Patients with Limited-Stage Small Cell Lung Cancer (LS-SCLC) at stage
2022-501608-85-00
5
2023-05-09
Cardiovascular disease (atherosclerotic cardiovascular disease (ASCVD)
2023-505552-22-00
5
2023-02-24
Stage I-III Triple-negative Breast Cancer with residual invasive disea
2023-503640-14-00
5
2022-02-17
Newly diagnosed Philadelphia-negative B-cell precursor Acute Lymphobla
2023-505695-30-00
5
2021-11-30
systemic lupus erythematosus
2023-506094-35-00
3
2021-09-17
Newly diagnosed aggressive B-cell lymphoma (a-BCL)
2024-512978-99-00
4
2021-07-19
Chronic graft versus host disease (cGVHD)
2023-504684-16-00
5
2021-06-05
follicular lymphoma (FL) and marginal zone lymphoma (MZL)
2022-501817-29-00
5
2018-11-27
High Risk Non-muscle invasive bladder cancer
2024-515959-38-00
4
2025-03-06
Hidradenitis Suppurativa
2022-500395-57-00
5
2019-03-04
Resectable high-risk Locally Advanced Cutaneous Squamous Cell Carcinom
2024-510779-39-00
4
2018-12-19
Neoplasm
Showing 97–117 of 117 trials